Greater pathogen burden but not elevated C-reactive protein increases the risk of clinical restenosis after percutaneous coronary intervention

The Bypass Angioplasty Revascularization Investigation (BARI) Investigators, 1996, Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease, N Engl J Med, 335, 217, 10.1056/NEJM199607253350401 Hannan, 1992, Percutaneous transluminal coronary angioplasty in New York State. Risk factors and outcomes, JAMA, 268, 3092, 10.1001/jama.1992.03490210074038 Kastrati, 1997, Predictive factors of restenosis after coronary stent placement, J Am Coll Cardiol, 30, 1428, 10.1016/S0735-1097(97)00334-3 Moscucci, 1994, Effect of prior coronary restenosis on the risk of subsequent restenosis after stent placement or directional atherectomy, Am J Cardiol, 73, 1147, 10.1016/0002-9149(94)90172-4 Teirstein, 1991, High-speed rotational coronary atherectomy for patients with diffuse coronary artery disease, J Am Coll Cardiol, 18, 1694, 10.1016/0735-1097(91)90505-4 Moussa, 1998, Stenting after optimal lesion debulking (SOLD) registry: angiographic and clinical outcome, Circulation, 98, 1604, 10.1161/01.CIR.98.16.1604 Weintraub, 1998, Outcome of coronary bypass surgery versus coronary angioplasty in diabetic patients with multivessel coronary artery disease, J Am Coll Cardiol, 31, 10, 10.1016/S0735-1097(97)00441-5 Stein, 1995, Influence of diabetes mellitus on early and late outcome after percutaneous coronary angioplasty, Circulation, 91, 979, 10.1161/01.CIR.91.4.979 Maseri, 1997, Inflammation, atherosclerosis, and ischemic events: exploring the hidden side of the moon, N Engl J Med, 336, 1014, 10.1056/NEJM199704033361409 Ross, 1995, Cell biology of atherosclerosis, Annu Rev Physiol, 57, 791, 10.1146/annurev.ph.57.030195.004043 Shah, 1995, Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques: potential role of matrix-degrading metalloproteinases and implications for plaque rupture, Circulation, 92, 1565 Ridker, 1996, Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men, N Engl J Med, 336, 973, 10.1056/NEJM199704033361401 Anderson, 1998, Evaluation of C-reactive protein, an inflammatory marker, and infectious serology as risk factors for coronary artery disease and myocardial infarction, J Am Coll Cardiol, 32, 35, 10.1016/S0735-1097(98)00203-4 Haverkate, 1997, Production of C-reactive protein and risk of coronary events in stable and unstable angina, Lancet, 349, 462, 10.1016/S0140-6736(96)07591-5 Kuller, 1996, Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study, Am J Epidemiol, 144, 537, 10.1093/oxfordjournals.aje.a008963 Patel, 1995, Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors, BMJ, 311, 711, 10.1136/bmj.311.7007.711 Saikku, 1988, Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction, Lancet, 2, 983, 10.1016/S0140-6736(88)90741-6 Melnick, 1990, Possible role of cytomegalovirus in atherogenesis, JAMA, 263, 2204, 10.1001/jama.1990.03440160066039 Muhlestein, 2000, Cytomegalovirus seropositivity and C-reactive protein have independent and combined predictive value for mortality in patients with angiographically-demonstrated coronary artery disease, Circulation, 102, 1917, 10.1161/01.CIR.102.16.1917 Zhu, 2000, Effects of total pathogen burden on coronary artery disease risk and C-reactive protein levels, Am J Cardiol, 85, 140, 10.1016/S0002-9149(99)00653-0 Zhu, 2001, Prospective study of pathogen burden and risk of myocardial infarction and death, Circulation, 103, 45, 10.1161/01.CIR.103.1.45 Anonymous, 1984, Myocardial infarction and mortality in the coronary artery surgery study (CASS) randomized trial, N Engl J Med, 310, 750, 10.1056/NEJM198403223101204 Forrester, 1991, A paradigm for restenosis based on cell biology: clues for the development of new preventive therapies, J Am Coll Cardiol, 17, 758, 10.1016/S0735-1097(10)80196-2 Violaris, 1994, Influence of serum cholesterol and cholesterol subfractions on restenosis after successful coronary angioplasty: a quantitative angiographic analysis of 3336 lesions, Circulation, 90, 2267, 10.1161/01.CIR.90.5.2267 Califf, 1992, Serum cholesterol in patients undergoing cardiac catheterization for suspected coronary artery disease: diagnostic and prognostic implications, Ann Epidemiol, 2, 137, 10.1016/1047-2797(92)90048-U Bertrand, 1997, Prevention of Restenosis by Elisor after Transluminal Coronary Angioplasty, J Am Coll Cardiol, 30, 863, 10.1016/S0735-1097(97)00259-3 Weintraub, 1994, Lack of effect on restenosis after coronary angioplasty, N Engl J Med, 331, 1331, 10.1056/NEJM199411173312002 Boccuzzi, 1998, Aggressive lipid lowering in postcoronary angioplasty patients with elevated cholesterol (the Lovastatin Restenosis Trial), Am J Cardiol, 81, 632, 10.1016/S0002-9149(97)00980-6 Zhou, 1999, Lack of association of restenosis following coronary angioplasty with elevated C-reactive protein levels or seropositivity to Chlamydia pneumoniae, Am J Cardiol, 84, 595, 10.1016/S0002-9149(99)00386-0 Buffon, 1999, Preprocedural serum levels of C-reactive protein predict early complications and late restenosis after coronary angioplasty, J Am Coll Cardiol, 34, 1512, 10.1016/S0735-1097(99)00348-4 Muhlestein, 1996, Increased incidence of Chlamydia species within the coronary arteries of patients with symptomatic atherosclerotic versus other forms of cardiovascular disease, J Am Coll Cardiol, 27, 1555, 10.1016/0735-1097(96)00055-1 Blasi, 1996, Detection of Chlamydia pneumoniae but not Helicobacter pylori in atherosclerotic plaques of aortic aneurysms, J Clin Microbio, 34, 2766, 10.1128/JCM.34.11.2766-2769.1996 Niemela, 1996, Could Helicobacter pylori infection increase the risk of coronary heart disease by modifying serum lipid concentrations?, Heart, 75, 573, 10.1136/hrt.75.6.573 Sung, 1996, Hyperhomocysteinaemia, Helicobacter pylori, and coronary heart disease, Heart, 76, 305, 10.1136/hrt.76.4.305 Speir, 1994, Potential role of human cytomegalovirus and p53 interaction in coronary restenosis, Science, 265, 391, 10.1126/science.8023160 Zhou, 1996, Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy, N Engl J Med, 335, 624, 10.1056/NEJM199608293350903 Blum, 1998, High anti-cytomegalovirus (CMV) IgG antibody titer is associated with coronary artery disease and may predict post-coronary balloon angioplasty restenosis, Am J Cardiol, 81, 866, 10.1016/S0002-9149(98)00019-8 Manegold, 1999, Prior cytomegalovirus infection and the risk of restenosis after percutaneous transluminal coronary balloon angioplasty, Circulation, 99, 1290, 10.1161/01.CIR.99.10.1290 Carlsson, 1997, Previous cytomegalovirus or Chlamydia pneumoniae infection and risk of restenosis after percutaneous transluminal coronary angioplasty [letter], Lancet, 350, 1225, 10.1016/S0140-6736(05)63456-3 Neumann, 2001, Effect of antibiotic treatment against Chlamydia pneumoniae with roxithromycin on neointima proliferation after coronary stent placement [abstract], J Am Coll Cardiol, 37, 9A Weintraub, 1998, Am J Cardiol, 81, 382, 10.1016/S0002-9149(97)00933-8